In vivo toxicity of bioreactor-grown biomass and exopolysaccharides from Malaysian tiger milk mushroom mycelium for potential future health applications

Abstract

Natural mycelial biomass (MB) and exopolysaccharides (EPS) of Malaysian tiger milk mushroom Lignosus rhinocerus are considered high-end components due to their high commercial potential value in drug discovery. This study aims to evaluate the toxicity of the mushroom extracts’ generated in a bioreactor using the zebrafish embryo toxicity (ZFET) model assay as a new therapy for treating asthma. Both MB and EPS extracts, at concentrations 0.16–10 mg/mL, were tested for ZFET and early development effects on Zebrafish Embryos (ZE) during 24–120 h post-fertilisation (HPF). Findings revealed that MB was deemed safe with an LC50 of 0.77 mg/mL; the EPS were non-toxic (LC50 of 0.41 mg/mL). Neither MB nor EPS delayed hatching nor teratogenic defects in the treated ZE at a 2.5 mg/mL dose. There were no significant changes in the ZE heart rate after treatments with MB (130 beats/min) and EPS (140 beats/min), compared to that of normal ZE (120–180 beats/min). Mixing both natural compounds MB and EPS did not affect toxicity using ZFET testing; thus, intimating their safe future use as therapeutic interventions. This represents the first study to have used the ZFET assay on MB and EPS extracts of L. rhinocerus for future health applications.

Filamentous fungi for sustainable remediation of pharmaceutical compounds, heavy metal and oil hydrocarbons

“…MnP uses hydrogen peroxide as a cofactor to oxidize a wide range of compounds, particularly lignin-derived compounds which are found in industrial effluents and are responsible for the color of the solution ( Bilal et al, 2016b ). The use of filamentous fungi in bioremediation processes can take place in different types of reactors, including solid-state fermentation, submerged fermentation, or adsorption-biodegradation ( Svobodová and Novotný, 2018 ; Zapana-Huarache et al, 2020 ; Usuldin et al, 2021 ). The process can be improved by optimizing the environmental conditions, such as pH, temperature, and oxygen availability, and by selecting the appropriate fungal strains.…”

“…Due to their easy bred, reared, easy laboratory maintenance, stability and ease of stable genetic manipulations, zebrafish are positioned as an ideal vertebrate model for in vivo studies compared to other vertebrates ( Tonelli et al, 2020 ). For example, a toxicity study of exopolysaccharides, obtained from medicinal mushroom mycelial extracts, conducted on zebra fish embryo has been used as safety screening approach prior to pre-clinical testing and considered as national and international standards ( Usuldin et al, 2021 ).…”

Digital transformation of peatland eco-innovations (‘Paludiculture’): Enabling a paradigm shift towards the real-time sustainable production of ‘green-friendly’ products and services

“…This IMTA system of Mount Lucas will provide solutions and data for wastewater management and be a model system for social marketing and studies of consumer awareness and acceptance of aquatic paludiculture processes (Domegan, 2021) that may lead to disruptive innovation (Schuelke-Leech, 2018;Schuelke-Leech, 2021a, 2021b. Mount Lucas will also enable emerging innovations such as oral vaccine testing and the potential use of other safety indicators (Taufek, 2020;Usuldin et al, 2021;Wan-Mohtar et al, 2021). The digital transformation "Terrain-AI" project uses drones across the peatlands for monitoring carbon sequestration as a means for sustaining carbon sinks (SFI, 2021).…”

Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain

“…There is a pressing need to reach international consensus and agreement on the defined production methods for bioactives produced from medicinal fungi for this potential purpose as batch-to-batch variation in production methods and types of mushrooms may generated different structural-bioactives that may lead to vary functional activities [ 67 , 131 , 132 ]. This situation will be addressed by promoting international collaborations between academia and industry partners in the areas of biotechnology, mycology, toxicology, bioinformatics and biopharma.…”